Clinical Roundup Merck, Moderna initiate phase III INTerpath-002 study evaluating V940 (mRNA-4157) + Keytruda in NSCLC indication January 05, 2024Vol.50 No.01
Clinical Roundup CAR T-cell therapy for T-cell lymphoma shows promise in phase I study January 05, 2024Vol.50 No.01
Clinical Roundup U.S. eAArly DETECT study evaluating novel mRNA CRC biomarkers produces positive topline results December 15, 2023Vol.49 No.46
Clinical Roundup Kadcyla produces OS benefit in HER2+ early-stage breast cancer with residual invasive disease after neoadjuvant treatment December 15, 2023Vol.49 No.46
Clinical Roundup Inavolisib combination reduces PFS advanced HR+, HER2- breast cancer with PIK3CA mutation December 15, 2023Vol.49 No.46
Clinical Roundup Darzalex Faspro-based quadruplet therapy regimen shows significant improvement in transplant-eligible newly diagnosed MM December 15, 2023Vol.49 No.46
Clinical Roundup JNCCN study: Real world data shows impact of immunotherapy in populations underrepresented in clinical trials December 15, 2023Vol.49 No.46
Clinical Roundup Trial shows atezolizumab combined with carboplatin has efficacy in TNBC December 15, 2023Vol.49 No.46
Clinical Roundup Women at high risk of breast cancer find novel decision-aid tool helpful, pilot study shows December 15, 2023Vol.49 No.46
Clinical Roundup Wistar study finds that common cholesterol drug enhances cell-based therapy December 15, 2023Vol.49 No.46
